Mechanical ventilation for pediatric patients

International Anesthesiology Clinics

Volumn 35, Issue 1, 1997, Pages 139-167

  Hammer, Gregory B ^a   Frankel, Lorry R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; FENTANYL; HYPNOTIC SEDATIVE AGENT; KETAMINE; LORAZEPAM; MIDAZOLAM; MUSCLE RELAXANT AGENT; OPIATE DERIVATIVE; PANCURONIUM; PHENCYCLIDINE DERIVATIVE; PIPECURONIUM; PROPOFOL; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ARTIFICIAL VENTILATION; CHILD; CHILDHOOD DISEASE; ENDOTRACHEAL INTUBATION; HUMAN; INFANT; INFANT DISEASE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW;

EID: 0030983687     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-199703510-00011     Document Type: Review

References (119)

1. Polgar G, Kong GP. Nasal resistance of newborn infants. J Pediatr 1965;67: 557-567
2. Bosma JF. Introduction to the symposium. In: Bosma JF, Showacre J, eds. Symposium on the development of upper respiratory anatomy and function: implications of Sudden Infant Death Syndrome. Washington, DC. US Government Printing Office, 1974:5-49
3. Cote CJ, Todres JD. The pediatric airway. In: Cote CJ, Ryan JF, Todres ID, Goudsouzian NG, eds. A practise of anesthesia for infants and children. 2nd ed. Philadelphia: WB Saunders Co, 1993:58-60
4. Butz RO. Length and cross-section growth patterns in the human trachea. Pediatrics 1968;42:336-341
5. Anthonisen NR, Danson J, Robertson PC, et al. Airway closure as a function of age. Respir Physiol 1969;8:58-65
6. Dawes GS. Fetal and neonatal physiology. Chicago: Yearbook Medical, 1973:191
7. Keens TG, Bryan AC, Levison H, et al. Developmental pattern of muscle fiber types in human ventilatory muscles. J Appl Physiol 1978;44:909-913
8. Drinker P, McKahnn CF. The use of a new apparatus for the prolonged administration of artificial respiration. JAMA 1929;92:1658-1660
9. Stern L, Ramos AD, Outerbridge EW, et al. Negative pressure artificial respiration: use in treatment of respiratory failure of the newborn. Can Med Assoc J 1970;102:595-560
10. Linsao LS, Aharon A, Levinson H, et al. Negative pressure artificial respiration: use in treatment of respiratory distress syndrome of the newborn. Can Med Assoc J 1970;102:602-606
11. Skaburskis M, Helal R, Zidulka A. Hemodynamic effects of external continuous negative pressure ventilation compared with those of continuous positive pressure ventilation in dogs with acute lung injury. Am Rev Resp Dis 1987;136:886-891
12. Sivak ED, Strieb EW. Management of hypoventilation in motor neuron disease presenting with respiratory insufficiency. Ann Neurol 1980;7:188-191
13. Braun NMT, Falkner J, Hughes RL, et al. When should respiratory muscles be exercised? Chest 1983;84:76-84
14. Gutierrez M, Beroiza T, Contreras G, et al. Weekly cuirass ventilation improves blood gases and inspiratory muscle strength in patients with chronic air-flow limitation and hypercarbia. Am Rev Resp Dis 1988;138:617-623
15. Wiers PWJ, Le Coultre R, Dallinga OT, et al. Cuirass respirator treatment of chronic respiratory failure in scoliotic patients. Thorax 1977;32:221-228
16. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:319-323
17. Gregory GA, Kitterman JA, Phibbs RH, et al. Treatment of the idiopathic respiratory distress syndrome with continuous positive airway pressure. NEJM 1971;284: 1333-3340
18. Moynihan RJ, Brock-Utne JG, Archer JH, et al. The effect of cricoid pressure on preventing gastric insufflation in infants and children. Anesthesiology 1993;78: 652-656
19. Deakers TW, Reynolds G, Stretton M, Newth CJ. Cuffed endotracheal tubes in pediatric intensive care. J Pediatr 1994;125:57-62
20. Besubder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate: critical evaluation of the pharmacokinetic-pharmacodynamic interface, Part 1. Clin Pharmacokinet 1988;14:189-216
21. Besubder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-pharmacodynamic interface, Part II. Clin Pharmacokinet 1988;14:261-286
22. Cote CJ, Goudsouzian NG, Liu LMP, et al. The dose-response for intravenous thiopental for the induction of general anesthesia in unpremedicated children. Anesthesiology 1981;55:703-705
23. Jonmarker C, Westrin P, Larsson S, et al. Thiopental requirements for induction of anesthesia in children. Anesthesiology 1987;67:104-107
24. Burch PG, Stanski DR. The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology 1983;58:146-152
25. Sorbo S, Hudson RJ, Loomis JC. The pharmacokinetics of thiopental in pediatric surgical patients. Anesthesiology 1984;61:666-670
26. Toner W, Howard PJ, McGowan WAW, et al. Another look at acute tolerance to thiopentone. Br J Anesth 1980;52:1005-1008
27. White PF. Propofol: pharmacokinetics and pharmacodynamics. Semin Anesth 1988;7:4-20
28. Mogensen F, Muller D, Valentin N. Glycopyrrolate during ketamine/diazepam anesthesia: a double-blind comparison with atropine. Acta Anaesthesiol Scand 1986;30:332-336
29. Hickey PR, Hansen DD, Cramolini GM, et al. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1985;62:287-293
30. Byer DE, Gould AB Jr. Development of tolerance to ketamine in an infant undergoing repeated anesthesia. Anesthesiology 1981;54:255-256
31. White PF, Ham J, Way WL, et al. Pharmacology of ketamine isomers in surgical patients. Anesthesiology 1980;52:231-239
32. Reich DL, Silvay G. Ketamine: an update on the first twenty five years of clinical experience. Can J Anaesth 1989;36:186-197
33. Mandeli M, Tongoni Garattini S. Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 1978;3:72-91
34. Salonen M, Kanto J, Iisalo E, et al. Midazolam as an induction agent in children: a pharmacokinetic and clinical study. Anesth Analg 1987;66:625-628
35. Deppe SA, Sipperly ME, Sargent AI, et al. Intravenous lorazepam as an amnestic and anxiolytic agent in the intensive care unit: a prospective study. Crit Care Med 1994;22:1248-1252
36. Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med 1994;22:1241-1247
37. Flacke JW, Flacke WE, Bloor BC, et al. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987;66:723-730
38. Martin DE, Rosenberg H, Aukburg SJ, et al. Low-dose fentanyl blunts circulatory responses to tracheal intubation. Anesth Analg 1982;61:680-684
39. Collin C, Koren G, Crean P, et al. Fentanyl pharmacokinetics and hemodynamic effects in preterm infants during ligation of patent ductus arteriosus. Anesth Analg 1985;64:1078-1080
40. Johnson KL, Erickson JP, Holley FO, et al. Fentanyl pharmacokinetics in the pediatric population. Anesthesiology 1984;61:A441
41. Koehntop DE, Rodman JH, Brundage DM, et al. Pharmacokinetics of fentanyl in neonates. Anesth Analg 1986;65:227-232
42. Stocking RK. Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine. Anesthesiology 1977;47:381-384
43. Meakin G, McKiernan EP, Morris P, et al. Dose-response curves for suxamethonium in neonates, infants and children. Br J Anaesth 1989;62:655-658
44. Cook DR. Muscle relaxants in infants and children. Anesth Analg 1981;60: 335-343
45. Widdowson EM. Changes in body proportion and composition during growth. In: Davis JA, Dobbing J, eds. Scientific foundations of paediatrics. London: William Heinemann Medical Books, 1974:153-163
46. Rosenberg H, Gronert GA. Intractable cardiac arrest in children given succinyl choline. Anesthesiology 1992;77:1054
47. Goodsouzian NG. Atracurium in infants and children. Br J Anaesth 1986;58: 23S-28S
48. Meakin G, Shaw EA, Baker RD, et al. Comparison of atracurium-induced neuromuscular blockade in neonates, infants and children. Br J Anaesth 1988;60: 171-175
49. Meretoja OA, Wirtavuori K, Neovonen PJ. Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia. Anesth Analg 1988;67:21-26
50. Goudsouzian NG, Martyn JAJ, Liu LMP, et al. The dose-response effect of long-acting neuromuscular blocking agents in children. Can Anaesth Soc J 1984;31: 246-250
51. Sarner JB, Brandom BW, Cook DR, et al. Clinical pharmacology of doxacurium chloride (BW A938U) in children. Anesth Analg 1988;67:303-306
52. Pittet JF, Tassonyi E, Morel DR, et al. Pipecuronium-induced neuromuscular blockade during nitrous oxide fentanyl, isoflurane and halothane anesthesia in adults and children. Anesthesiology 1989;71:210-213
53. Vuksanaj D, Fisher DM. Pharmacokinetics of rocuronium in children aged 4-11 years. Anesthesiology 1995;82:1104-1110
54. Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 1993;79:913-918
55. Tobias JD. Lorazepam vs. midazolam for sedation. Crit Care Med 1995;23: 1151-1152
56. Rall TW. Hypnotics and sedatives: ethanol. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacologic basis of disease. New York: Pergamon Press, 1990:345-382
57. Laxenaire MC, Mata-Bermejo E, Moneret-Vautrin DA, et al. Life-threatening anaphylactoid reactions to propofol (Diprivan). Anesthesiology 1992;77:275-280
58. Gottardis M, Khunl-Brady KS, Koller W, et al. Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations. Br J Anaesth 1989; 62:393-396
59. Bergman I, Sleeves M, Burckart G, Thompson A. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr 1991;119:644-648
60. Lane JC, Tennison MB, Lawless ST, et al. Movement disorder after withdrawal of fentanyl infusion. J Pediatr 1991;119:649-651
61. Mushin WW, Rendell-Baker L, Thompson PW, Mapleson WW. Clinical aspects of controlled respiration. In: Automatic ventilation of the lungs. Oxford: Blackwell Scientific, 1980:33-61
62. Nelson NM. Neonatal pulmonary function. Pediatr Clin North Am 1966;13: 769-799
63. Doershuk CF, Fisher BJ, Matthews LW. Pulmonary physiology of the young child. In: Scarpelli EM, ed. Pulmonary physiology of the fetus, newborn, and child. Philadelphia: Lea and Febiger, 1975:166
64. Auld PAM. Pulmonary physiology of the newborn infant. In Scarpelli EM, ed. Pulmonary physiology of the fetus and newborn child. Philadelphia: Lea and Febiger, 1975:140
65. Heldt GP, Bernstein G. Patient initiated mechanical ventilation. In: Boynton BR, Carlo WA, Jobe AH, eds. New therapies for neonatal respiratory failure: a physiologic approach. New York: Cambridge University Press, 1994:152-170
66. Cleary JP, Bernstein G, Heldt GP, et al. Improved oxygenation during synchronized intermittent mandatory ventilation in neonates with respiratory distress syndrome: a randomized cross-over study. J Pediatr 1995;126:407-411
67. Bernstein G, Knodel E, Heldt GP. Airway leak size in neonates and autocycling of three flow-triggered ventilators. Crit Care Med 1995;23:1739-1744
68. Marini J. The role of inspiratory circuit in the work of breathing during mechanical ventilation. Respir Care 1987;32:419-430
69. MacIntyre N. Pressure support ventilation. Respir Care 1986;31:189-190
70. El-Khatib MF, Chatburn RL, Potts DL, et al. Mechanical ventilators optimized for pediatric use decrease work of breathing and oxygen consumption during pressure-support ventilation. Crit Care Med 1994;22:1942-1948
71. Cox D, Tinloi SF, Farrimond JG. Investigation of the spontaneous modes of breathing of different ventilators. Intensive Care Med 1988;14:532-537
72. Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnea: a prospective study. Crit Care Med 1994;22:1568-1578
73. Rappaport SH, Shpiner R, Yoshihara G, et al. Randomized, prospective trial of pressure-limited ventilation in severe respiratory failure. Crit Care Med 1994;22: 22-32
74. Paulson TE, Spear RM, Peterson BM. Improved survival using high frequency pressure control ventilation with high PEEP in children with ARDS. Crit Care Med 1993;21:S290
75. Marcy Y, Marini JJ. Inverse ratio ventilation in ARDS. Rationale and implementation. Chest 1991;100:494-504
76. DeBruin W, Notterman DA, Magid M, et al. Acute hypoxemic respiratory failure in infants and children: clinical and pathologic characteristics. Crit Care Med 1992; 20:1223-1234
77. Timmons OD, Dean JM, Vernon DD. Mortality and prognostic variables in children with adult respiratory distress syndrome. J Pediatr 1991;119:896-899
78. Davis SL, Furman DP, Costarino AT. Adult respiratory distress syndrome in children: associated disease, clinical course and predictors of death. J Pediatr 1993; 123:35-45
79. Timmons OD, Havens PL, Fackler JC, et al. Predicting death in pediatric patients with acute respiratory failure. Chest 1995;108:789-797
80. Froese AB, Bryan AC. High frequency ventilation. Am Rev Resp Dis 1987;135: 1363
81. Wetzel RC, Gioia FR. High frequency ventilation. Pediatr Clin North Am 1987; 34:15-38
82. Gerstmann DR, DeLemos RA, Clark RH. High frequency ventilation: issues of strategy. Clin Perinatol 1991;18:563
83. Boros SJ, Mammel MC, Coleman JM, et al. Neonatal high frequency jet ventilation: four years' experience. Pediatrics 1985;75:657
84. Corbridge TC, Wood LDH, Crawford GP, et al. Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Resp Dis 1990;142: 311-315
85. Dreyfuss D, Soler P, Basset G, et al. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume and positive end-expiratory pressure. Am Rev Resp Dis 1988;137:1159-1184
86. Clark RH, Gerstmann DR, Null DM, et al. Prospective, randomised comparison of high frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 1992;89:5-12
87. HiFO Study Group. Randomised study of high frequency oscillatory ventilation in infants with severe respiratory distress syndrome. J Pediatr 1993;122:609-619
88. Arnold JH, Hanson JH, Toro-Figuero LO, et al. Prospective, randomized comparison of high frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994;22:1530-1539
89. O'Rourke P, Crone R, Vacanti J, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989;84:957
90. Neonatal ECMO Registry Report of the Extracorporeal Life Support Organization (ELSO). Ann Arbor, MI: University of Michigan, April 1994
91. Adolph V, Heaton J, Steiner R, et al. Extracorporeal membrane oxygenation for non-neonatal respiratory failure. J Pediatr Surg 1991;26:326
92. Moler FW, Palmisano J, Custer JR. Extracorporeal life support for pediatric respiratory failure: predictors of survival from 220 patients. Crit Care Med 1993;21: 1604
93. Moler FW, Custer JR, Bartlett RH, et al. Extracorporeal life support for severe pediatric respiratory failure: an updated experience 1991-1993. J Pediatr 1994; 124:875
94. Green TP, Timmons OD, Fackler JG, et al. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Crit Care Med 1996;24:323-329
95. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959;97:517
96. Robillard E, Alarie Y, Dagqnais-Perusse P, et al. Microaerosol administration of synthetic dipalmitoyl-L-alpha-lecithin in respiratory distress syndrome: a preliminary report. Can Med Assoc J 1964;90:55
97. Merritt TA, Soll RF, Hallman M. Overview of exogenous surfactant replacement therapy. J Intensive Care Med 1993;8:205
98. Nosaka S, Sakai T, Yonekura M, et al. Surfactant for adults with respiratory failure. Lancet 1990;336:947
99. Richman PS, Spragg RG, Robertson B, et al. The adult respiratory distress syndrome: first trials with surfactant replacement. Eur Respir J 1989;2:109
100. Weg J, Reines H, Balk R, et al. Safety and efficacy of an aerosolized surfactant in human sepsis induced ARDS. Chest 1991;100:137
101. Weidemann H, Baughman R, deBoisblanc B, et al. A multi-centered trial in human sepsis induced ARDS of an aerosolized synthetic surfactant. Am Rev Resp Dis 1992;145:A184
102. Kinsella JP, Neish SR, Ivy DD, et al. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993;123:103
103. Roberts JD Jr, Polaner DM, Lang P, et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818
104. Wessel DL, Aditia I, Thompson J, et al. Inhaled nitric oxide (NO) for the treatment of pulmonary hypertension before and after cardiopulmonary bypass. Circulation 1992;86:1-776
105. Roberts JD Jr, Lang P, Bigatello LM, et al. Inhaled nitric oxide in congenital heart disease. Circulation 1992;87:447
106. Kinsella JP, Neish SR, Shaffer E, et al. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819
107. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405
108. Abman SH, Griebel JL, Parker DK, et al. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994;124:881-888
109. Bigatello LM. Hurford WE, Kacmarek RM, et al. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome: effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994;80:761-770
110. Puybasset L, Stewart T, Rouby JJ, et al. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnea in patients with acute respiratory distress syndrome. Anesthesiology 1994;80:1254-1267
111. Putensen C, Rasanen J, Downs JB, et al. Effect of endogenous and inhaled nitric oxide on the ventilation-perfusion relationships in oleic acid lung injury. Am J Resp Crit Care Med 1994;150:330-336
112. Day RW, Guarin M, Lynch JM, et al. Inhaled nitric oxide in children with severe lung disease: results of acute and prolonged therapy with two concentrations. Crit Care Med 1996;24:215-221
113. Greenspan JS. Liquid ventilation: a developing new technology. Neonatal Network 1993;12:23
114. Shaffer TH, Wolfson MR, Clark LC Jr. Liquid ventilation. Pediatr Pulmonol 1992; 14:102
115. Greenspan JS, Wolfson MR, Rubenstein D, et al. Liquid ventilation of human preterm neonates. J Pediatr 1990;117:106
116. Shoults D, Clarke TA, Benumof JL, Manning FL. Maximum inspiratory force in predicting successful neonatal tracheal extubation. Crit Care Med 1979;7:485
117. Shimada Y, Yoshya I, Tanaka K, et al. Crying vital capacity and maximal inspiratory pressure as clinical indicators of readiness for weaning of infants less than a year of age. Anesthesiology 1979;51:456
118. LeSouef PN, England SJ, Bryan AC. Total resistance of the respiratory system in preterm infants with and without an endotracheal tube. J Pediatr 1984;104:108
119. Wall MA. Infant endotracheal tube resistance: effects of changing length, diameter and gas density. Crit Care Med 1980;8:38